glp-1 and osteoporosis AAOS | A new study presented at #AAOS2026 revealed use may be linked to a 29% higher risk of after five years. As use of Potential mechanism of glucagon-like peptide-1

Abstract Purpose of Review This review provides a comprehensive and scholarly examination of glucagon-like peptide-1 receptor (GLP-1R) agonists, tracing their evolution from glycemic control agents in diabetes mellitus (DM) to multifaceted therapeutics with expanding indications in cardiovascular, renal, and metabolic health

The 503b pharmacies are regulated by the FDA, and some of them do contract manufacturing for pharmaceutical companies

Daniel Cottam explores how testosterone and estradiol supplementation can help surgical weight-loss patients preserve muscle, improve metabolism, elevate mood, and even reduce risks of cancer and heart diseaseall at a fraction of the cost of GLP-1 medications

Endocrinologists unraveled gut hormones

Aortic Regurgitation Is Common in Ankylosing Spondylitis: Time for Routine Echocardiography Evaluation